ArticleThe Journal of clinical investigation2023

Anticancer pan-ErbB inhibitors reduce inflammation and tissue injury and exert broad-spectrum antiviral effects.

Sirle Saul et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.